Evidence map›Paper›PMID 30008966›Full record

ArticleThe open infectious diseases journal2018

Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan.

Sana Hussain, Jamshed Hasnain, Zareen Hussain, Masroor Badshah, Hafeez Siddique, Christina Fiske, April Pettit

Abstract read
In one paragraph

Article in The open infectious diseases journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sana HussainShaheed Zulfiqar Ali Bhutto Institute of Science and Technology, (SZABIST), Karachi, Pakistan.
Jamshed HasnainBridge Consultants Foundation, Karachi, Pakistan.
Zareen HussainZiauddin University, Karachi, Pakistan.
Masroor BadshahNorthwest School of Medicine, Peshawar, Pakistan.
Hafeez SiddiqueBridge Consultants Foundation, Karachi, Pakistan.
Christina FiskeVanderbilt University, Nashville, TN, USA.
April PettitVanderbilt University, Nashville, TN, USA.

Funding

Tuberculosis Risk and Highly Active Antiretroviral Therapy InitiationK08AI104352 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PETTIT, APRIL · 2013 to 2016
$541k
NIAID NIH HHS K08 AI104352
6 · The paper itself

Abstract

backgroundThe World Health Organization has recommended a patient-centered approach to tuberculosis drug administration. A central element of the patient-centered strategy is the use of treatment supporters to evaluate and elevate adherence to the treatment regimen and to address poor adherence when it occurs. This study was led to determine the part of various treatment supporters in the successful completion of treatment.

methodThis study was conducted in two locales of Sindh, Hyderabad and Mirpurkhas. Information gathered included age, gender, regions, sort of treatment supporters (relatives, community and health facility workers) and treatment outcomes.

resultsOf the 773 patients incorporated into the study, 86.8% picked a family supporter, 7.63% selected community worker and 5.56% chose health facility worker as their treatment supporter. Women and younger patients were more likely to prefer that family members supervise their treatment. Treatment achievement rates among the patients regulated by the three kinds of treatment supporters, were not altogether unique in relation to each other (

conclusionThe study demonstrates that TB patients ought to be urged to pick the supporter of their inclination as selection of treatment supporter outside the health system does not adversely affect TB treatment outcomes in limited resource settings.

Indexed as

Family memberSindhTBTB DOTsTreatment outcomeTreatment Supporters

Identifiers

PMID30008966
PMCPMC6044441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.